How much is Vor Biopharma worth in 2026?

Vor Biopharma has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Vor Biopharma raised?

Vor Biopharma has raised N/A in total funding across 4 funding rounds.

Vor Biopharma

Drug Discovery

Vor Biopharma valuation and funding history | Last updated: December 15, 2025 | 4 funding rounds

Current Valuation

N/A

As of December 15, 2025

Total Funding Raised

N/A

Across 4 rounds

Last Round

PIPE

$150.0M

Last Funding

Dec 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 15, 2025	PIPE	$150.0M	N/A	-
June 27, 2025	PIPE	$175.0M	N/A	-
December 27, 2024	PIPE	$55.5M	N/A	-
December 8, 2022	PIPE	$50.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Vor Biopharma is currently valued at N/A as of December 15, 2025.

Track Vor Biopharma Valuation Updates

Get notified when Vor Biopharma raises new funding or valuation changes

Explore More Data

Detailed analysis for Vor Biopharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Vor Biopharma's valuation history, funding rounds, and growth metrics.

No credit card required

What is Vor Biopharma Worth in 2026?

Vor Biopharma is a leading private company in the Drug Discovery sector. Track Vor Biopharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Vor Biopharma Valuation is Determined

Private company valuations like Vor Biopharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.